Alto Neuroscience Inc — Quarterly Cash Flow (NYSE:ANRO) | MetaTrader

Open full chart

Financials

Overview Relevé Statistics Dividends

Quarterly Annual

Total assets 191.61 M177.54 M171.91 M157.88 M147.01 M Total liabilities 26.56 M26.08 M32.82 M34.47 M35.45 M Total equity 165.05 M151.46 M139.1 M123.41 M111.56 M Total liabilities & shareholders' equities 191.61 M177.54 M171.91 M157.88 M147.01 M Total debt ————— Net debt —————

Nouvelles

Alto Neuroscience завершает набор пациентов в испытании препарата от шизофрении

Alto Neuroscience completes enrollment in schizophrenia drug trial

Alto Neuroscience получает патент на метод лечения депрессии

Alto Neuroscience receives patent for depression treatment method

Chardan Capital Markets начинает освещение акций Alto Neuroscience

Chardan Capital Markets assumes coverage on Alto Neuroscience stock with Buy rating

Tesla and ServiceNow among market cap stock movers on Monday

Alto Neuroscience: 4 Shots At Success In CNS Diseases In 2026 (NYSE:ANRO)

Google, Alibaba among market cap stock movers on Monday

Jazz Pharmaceuticals, Sigma Lithium, Zymeworks And Other Big Stocks Moving Higher On Monday - Alto Neuroscience (NYSE:ANRO), Albemarle (NYSE:ALB)

BTIG начинает покрытие акций Alto Neuroscience с рейтингом "Покупать"

Alto Neuroscience stock initiated at Buy by BTIG on precision psychiatry approach